HNGE · NYSE · STOCK
Hinge Health (HNGE) Stock Analysis
$102.86
52W $30.08 – $103.28
66/100
$7.96B
76.4
1.36
Is HNGE Bullish or Bearish?
Bullish.
Innellis AI committee rates Hinge Health, Inc. (HNGE) Buy with a composite score of 66/100
, based on 6 analysts with 83% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +9.21 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -10.79 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 30.2% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 76.1 is expensive by classic value standards — Value
- Price-to-book of 9.7x prices in significant intangible value — Value
- RSI at 78 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
- Weekly RSI at 78 -- overbought on the larger timeframe too — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
66/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 2%
of 192 Healthcare peers
Value Analyst
neutral
49
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 30.2% shows genuine earnings power backing the valuation
− P/E of 76.1 is expensive by classic value standards
Growth Analyst
bullish
75
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− RSI at 78 is in overbought territory
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
65
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.22 across 9 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 67.0 to 65.8.
- New bearish signals: 4 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Technical Analyst: score 69->61 (-8); +3 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
77.7
Overbought
MACD Histogram
0.341
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
1.15
Above Upper Band
Price vs Moving Averages
EMA 9
$98.23
Above
EMA 21
$95.80
Above
EMA 50
$90.75
Above
EMA 200
$70.13
Above
Fundamental Analysis
Valuation
33
Growth
78
Profitability
44
Financial Health
72
Cash Flow
70
Valuation
P/E Ratio
76.4×
P/B Ratio
23.55×
PEG Ratio
1.01
Dividend Yield
0.00%
52W High
$103.28
52W Low
$30.08
Quality & Growth
ROE
-13955.4%
ROA
-7093.0%
Gross Margin
8452.0%
Operating Margin
1300.9%
Revenue Growth YoY
—
Debt / Equity
0.02
AI Fundamental Assessment
P/E ratio of 76.4 (rich relative to a 15-40x range); Price-to-book of 23.5x; PEG ratio of 1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -139.6%; Return on assets of -70.9%; Net margin of 15.1%; Gross margin of 84.5%; Current ratio of 1.34 (tight short-term liquidity); Debt-to-equity of 0.02; Free cash flow per share is positive (3.65); Most recent quarter missed estimates by 1.9%; EPS growth accelerating (-8.2% -> +31.1% QoQ); Analyst estimates rising over recent quarters
Get the Full HNGE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →